TScan Therapeutics Announces Closing of Upsized Public Offering
Go back to TScan Therapeutics Announces Closing of Upsized Public Offering| Dreyfus/Laurel Funds Trust Dreyfus Core Value Fund Class I (NASDAQ: TCRX) | Delayed: 1.03 -0.06 (5.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.09 | 52 Week High | $26.80 | |||
| Open | $1.07 | 52 Week Low | $23.00 | |||
| Day High | $1.10 | P/E | N/A | |||
| Day Low | $1.02 | EPS | $0.00 | |||
| Volume | 1,152,420 | |||||
